News and Announcements
MedAdvisor Signs Agreement with Novartis Pharmaceuticals to Deliver Patient Engagement & Education Program
- Published May 30, 2016 12:05PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
30th May 2016, ASX Announcement
Highlights:
- MedAdvisor signs a 12 month agreement with Novartis Pharmaceuticals Australia to deliver patient engagement and education program via the MedAdvisor platform
- Program will provide educational resources for patients, helping ensure they take their medications as prescribed to help improve patient adherence and quality use of medicines (QUMs)
- The program is to commence in June 2016 with three products initially and will run for 12 months
MedAdvisor Limited (ASX:MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed a 12 month agreement to collaborate with Novartis Pharmaceuticals Australia.
To view the full announcement, please click on the button below.
Company Updates
Beyond the Balance Sheet: Building for a Strategic Premium in Your Business Exit
To achieve an exceptional business exit, focusing solely on financials isn’t enough. This article explores how to build a “strategic premium” by positioning your business as an indispensable asset for specific acquirers. Learn what strategic buyers truly seek, how to build this value before you sell, and how to craft a compelling narrative that secures higher valuations and better deal terms.
Cosmo Innovations Founder Eyes Global Rollout of SkinGate, IPO by 2027
Dr. Mathew Jafarzadeh, founder of Cosmo Innovations, is set to revolutionize the $65 billion home beauty tech market with SkinGate, a patented skincare infusion device. Following his presentation at Emergence 2025, he revealed plans for a global rollout, aiming for a 2027 IPO on NASDAQ or the Hong Kong Exchange. Discover how SkinGate, backed by 110+ patents, seeks to attract “smart capital” and redefine skincare delivery.
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!
In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]
Backed By Leading Investment Groups and Family Offices
